![Chemical structure of [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione, CAS 114-07-8](https://api.angenesci.com/structure/3486/114-07-8.png)
No data
No data
No data
| CAS Number | 114-07-8 |
| Catalog Number | AG0039A1(AGN-PC-0P5RUK) |
| Chemical Name | [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione |
| IUPAC Name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
| InChI | InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 |
| InChI Key | ULGZDMOVFRHVEP-RWJQBGPGSA-N |
| MDL Number | MFCD00149235 |
| Molecular Formula | C37H67NO13 |
| Molecular Weight | 733.9268 |
| NSC Number | 756759 |
| SMILES | C[C@@H](C([C@H](C)C[C@](O)(C)[C@H](O[C@@]2([H])[C@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[C@@H](C)[C@H](C[C@@]3([H])C[C@](OC)(C)[C@@H](O)[C@H](O)O3)[C@H]1C)=O)[C@@H](O)[C@@](O)(C)[C@@H](CC)OC1=O |
| UNII | 63937KV33D |
| Synonyms | Erycette,
Erymax,
Erythromycin,
Erythromycin A,
Erythromycin C,
Erythromycin Lactate,
Erythromycin Phosphate,
Ilotycin,
Lactate, Erythromycin,
Phosphate, Erythromycin,
T Stat,
T-Stat,
TStat,
erythromycin,
Erythromycin A,
114-07-8,
E-Mycin,
Abomacetin,
Erythrocin,
Erythromycinum,
Erymax,
Ilotycin,
Erythromycine,
Eritromicina,
Emgel,
Robimycin,
Erythro-Statin,
E-Glades,
E-Base,
erythro,
Benzamycin,
Dumotrycin,
Mephamycin,
Eryacne,
Sansac,
Eryc Sprinkles,
Erythra-Derm,
Akne-Mycin,
Erythromycin base,
R-P Mycin,
(-)-ERYTHROMYCIN,
Wemid,
E-Solve 2,
Torlamicina,
Abboticin,
Erycette,
Eryc 125,
Ery-Tab,
Erythroguent,
Eritrocina,
Erycinum,
Erythrogran,
Erythromid,
Pantomicina,
Propiocine,
Stiemycin,
Dotycin,
Ermycin,
Erycen,
Erycin,
Eryderm,
Erygel,
Ilocaps,
Aknin,
ERYC,
Pfizer-E,
Theramycin Z,
Kesso-Mycin,
Taimoxin-F,
Ak-Mycin,
Erythromast 36,
Erythromycin Lactate,
T-Stat,
Endoeritrin,
Eritomicina,
Erythroderm,
Erytrociclin,
MFCD00084654,
Paediathrocin,
Pharyngocin,
Proterytrin,
Acneryne,
Acnesol,
Aknemycin,
Derimer,
Deripil,
Erisone,
Eryacnen,
Erydermer,
Eryhexal,
Erysafe,
Iloticina,
Latotryd,
Lederpax,
Mercina,
Oftamolets,
Pantoderm,
Pantodrin,
Primacine,
Romycin,
Stiemicyn,
Tiloryth,
Tiprocin,
Emuvin,
Emycin,
Erecin,
Erymed,
Erytab,
Erytop,
Inderm,
Retcin,
AustriaS,
Eros,
Ery-maxin,
Erythro-Teva,
Sans-acne,
Erimycin-T,
Ery-Diolan,
Inderm Gel,
Del-Mycin,
UNII-63937KV33D,
Wyamycin S,
Aknederm Ery Gel,
Udima Ery Gel,
Emu-Ve,
Erythrocin stearate,
Skid Gel E,
Akne Cordes Losung,
Ilosone (estolate),
E-Mycin (base),
Ery-Tab (base),
E-Base (base),
Emu-V,
Ery-B,
CHEMBL532,
ERYC (base),
C-Solve-2,
ERYTHROMYCIN STEARATE,
PCE Dispertab (base),
IndermRetcin,
erythromycin-A,
Eryc-125,
Eryc-250,
CHEBI:42355,
ULGZDMOVFRHVEP-RWJQBGPGSA-N,
Eritromicina [INN-Spanish],
Erythromycine [INN-French],
Erythromycinum [INN-Latin],
A/T/S,
Oftalmolosa Cusi Eritromicina,
63937KV33D,
Ilotycin gluceptate,
NCI-C55674,
DSSTox_CID_2991,
(-)-Erythromycin, 98%,
UNII-8HPH7ND0LN,
DSSTox_RID_76820,
DSSTox_GSID_22991,
8HPH7ND0LN,
(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione,
ERY,
Ilotycin T.S.,
(-)-Erythromycin, Eur.Ph.,
CCRIS 9078,
HSDB 3074,
N-Methylerythromycin A,
EINECS 204-040-1,
NSC 55929,
Ery-Sol,
Staticin (TN),
(2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan-13-olide,
Akne-mycin (TN),
AI3-50138,
Erygel (TN),
Eryc (TN),
T-stat (TN),
Pce (TN),
SR-05000001618,
Sentry AQ mardel maracyn,
erthromycin,
Erythromycines,
ULGZDMOVFRHVEP-UHFFFAOYSA-N,
NSC55929,
NCGC00094670-01,
Erythromycin [USP:INN:BAN:JAN],
82343-12-2,
CAS-114-07-8,
Prestwick_205,
Erythromycin C-13,
E-mycin, Erythrocin,
Erythromycin(E-Mycin),
Spectrum_000115,
Spectrum_000659,
AC1L1ZUR,
EM-A,
Prestwick3_000151,
Spectrum2_000759,
Spectrum2_001263,
Spectrum4_000538,
Spectrum5_001596,
E0751,
Erythromycin A, B + C,
EC 204-040-1,
SCHEMBL2601,
BSPBio_000282,
BSPBio_002480,
KBioGR_001175,
KBioSS_000555,
KBioSS_001139,
MLS001066618,
BIDD:GT0017,
DivK1c_000294,
DivK1c_000397,
DivK1c_000702,
SPECTRUM1500280,
SPBio_000778,
SPBio_001226,
BPBio1_000312,
GTPL1456,
CHEMBL3735423,
DTXSID4022991,
Erythromycin (JP17/USP/INN),
HMS500O16,
KBio1_000294,
KBio1_000397,
KBio1_000702,
KBio2_000555,
KBio2_001139,
KBio2_003123,
KBio2_003707,
KBio2_005691,
KBio2_006275,
Erythromycin (mixture of A,B,C),
NINDS_000294,
NINDS_000397,
NINDS_000702,
ZX-AFC000696,
HMS1920M04,
HMS2091D05,
HMS2095O04,
HMS3712O04,
Pharmakon1600-01500280,
ACT03320,
HY-B0220,
RKL10096,
Tox21_111311,
Tox21_111869,
Tox21_300515,
BDBM50344942,
CCG-38992,
LMPK04000006,
NSC756759,
ZINC85534336,
Erythromycin, labeled with carbon-13,
AKOS015895249,
CS-2168,
DB00199,
MCULE-4566208867,
NSC-756759,
IDI1_000294,
IDI1_000397,
IDI1_000702,
SMP1_000119,
NCGC00179619-01,
NCGC00179619-02,
NCGC00179619-03,
NCGC00254234-01,
AC-12744,
AC-12901,
BC205124,
CC-27517,
CPD000544946,
SAM002643510,
SC-13736,
SMR000544946,
Erythromycin, potency: >=850 mug per mg,
Erythromycin, tested according to Ph.Eur.,
SBI-0051368.P003,
Erythromycin, N-demethyl-N-(methyl-11C)-,
LS-187077,
Erythromycin, meets USP testing specifications,
C01912,
D00140,
E-3250,
Erythromycin, plant cell culture tested, ~98%,
44496-EP2272846A1,
44496-EP2275422A1,
44496-EP2292608A1,
44496-EP2305644A1,
44496-EP2308866A1,
44496-EP2311814A1,
44496-EP2311828A1,
44496-EP2380568A1,
AB00051981_09,
AB00051981_10,
Erythromycin standard solution, 1 mg/mL in H2O,
Erythromycin, Biotechnology Performance Certified,
114E078,
C-23475,
SR-01000799155,
9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione,
Erythromycin, Antibiotic for Culture Media Use Only,
Erythromycin, BioReagent, suitable for cell culture,
SR-01000799155-2,
SR-05000001618-1,
SR-05000001618-2,
BRD-K63550407-001-13-5,
BRD-K63550407-028-03-9,
Erythromycin A, British Pharmacopoeia (BP) Reference Standard,
Erythromycin A, European Pharmacopoeia (EP) Reference Standard,
Erythromycin, United States Pharmacopeia (USP) Reference Standard,
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard,
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material,
(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione,
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name),
215031-94-0,
Bristamycin,
Erypar,
Erythromycin C,
Staticin,
Benzamycin Pak,
Erythromycin B,
Abboticine,
Gallimycin,
Qidmycin,
Eratrex,
Ilosone,
Meberyt,
Ethril,
TStat,
Dowmycin E,
Erythromycin oxime,
Ilotycin T.S,
T Stat,
Ethril 250,
Serp-AFD,
Ilosone (TN),
Erythromycin thiocyanate,
Erythromycin Ointment,
erythromycin lactobionate,
Erythromycin phosphate,
Lactate, Erythromycin,
Erythromycin intravenous,
Phosphate, Erythromycin,
3''-O-Demethylerythromycin,
erythromycin ethylsuccinate,
Erythromycin glucoheptonate,
D02YIZ,
Erythromycin [INN:BAN:JAN],
Erythromycin & VRC3375,
ERYTHROMYCIN ESTOLATE,
E-mycin, Erycin, Robimysin,
ETHRIL 500,
UNII-LXW024X05M,
Erythromycin stearate (salt),
ERYTHROMYCIN GLUCEPTATE,
Erythromycin, stearate (salt),
Erythromycin [BAN:INN:JAN],
Erythromycin steraric acid salt,
CCRIS 1504,
OE 7,
Erythromycin (JP15/USP/INN),
HSDB 4178,
Erythromycin octadecanoate (salt),
Erythromycin stearate [BAN:JAN],
Erythromycin octadecanoate (1:1),
Erythromycin sodium lauryl sulfate,
C37H67NO13,
Erythromycin, octadecanoate (salt),
ERYTHROMYCIN USP GRADE 10G,
CID12560,
DRG-0279,
EINECS 211-396-1,
C37-H67-N-O13,
Erythromycin stearate [USP:BAN:JAN],
ACN-048190,
CS-O-01436,
CS-O-11641,
Octadecanoato de Eritromicina, (1:1),
C37H67NO13.C18H36O2,
NCGC00160521-01,
adecane-2,10-dione (non-preferred name),
B1939,
Stearic acid, compd. with erythromycin (1:1),
C37-H67-N-O13.C18-H36-O2,
D004917,
Octadecanoic acid, compd. with erythromycin (1:1),
PCE,
Erythromycin, 88%, potency:>/=920 u/mg - 25G 25g,
Erythromycin, compd. with monododecyl sulfate, sodium salt,
643-22-1,
7704-67-8,
EM,
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279,
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin,
,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione,
1675-02-1,
EMU,
ETs,
|
| Complexity | 1180 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 18 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 733.461g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 51 |
| Hydrogen Bond Acceptor Count | 14 |
| Hydrogen Bond Donor Count | 5 |
| Isotope Atom Count | 0 |
| Molecular Weight | 733.937g/mol |
| Monoisotopic Mass | 733.461g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 194A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.7 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H319 |
| Packing Group | |
| Precautionary statements | P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

